Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear
Michel BOURGUIGNON | Head of Department | Professor Emeritus of Biophysics and Nuclear Medicine, MD, PhD-University Paris Saclay (UVSQ) - Editor in chief RADIOPROTECTION - INSERM unit UMR1296 Radiations: Defense Health Environment
Médecine nucléaire - Commission canadienne de sûreté nucléaire
La médecine nucléaire, un outil pour détecter le cancer - Sciences et Avenir
CANCERS RADIO-INDUITS J.M. COSSET Institut Curie, Paris - ppt télécharger